dc.contributor.author | García-Portilla González, María Paz | |
dc.contributor.author | Llorca, P. M. | |
dc.contributor.author | Maina, G. | |
dc.contributor.author | Bozikas, V. P. | |
dc.contributor.author | Devrimci Ozguven, H. | |
dc.contributor.author | Kim, S. W. | |
dc.contributor.author | Bergmans, P. | |
dc.contributor.author | Usankova, I. | |
dc.contributor.author | Cherubin, P. | |
dc.contributor.author | Pungor, K. | |
dc.date.accessioned | 2019-08-21T07:33:19Z | |
dc.date.available | 2019-08-21T07:33:19Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 0924-977X | |
dc.identifier.issn | 1873-7862 | |
dc.identifier.uri | http://hdl.handle.net/10651/51899 | |
dc.description | European College of Neuropsychopharmacology, ECNP Congress (31st, 2018, Barcelona, Spain) | |
dc.format.extent | p. S238-S239 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Neuropsychopharmacology, 29(S1) | |
dc.rights | © 2018 Published by Elsevier B.V. | |
dc.source | WOS:000458400500326 | |
dc.title | Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use | |
dc.type | conference output | spa |
dc.identifier.doi | 10.1016/j.euroneuro.2018.11.383 | |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.euroneuro.2018.11.383 | |